Cutaneous (Skin) Cancer Treatment Center
Our Services
Prevention and Screening
Dermatologists educate patients and family members about prevention and early detection of cutaneous cancer and examine the skin for any suspicious lesions, such as moles and other abnormal skin marks.
Studies of Familial Melanoma
Researchers are involved in finding the basic causes of malignant melanoma. They provide information about the inherited form of the disease and genetic risk factors. Genetic testing is available in a clinical trial.
Histopathologic Diagnosis and Review
Clinicians diagnose patients with melanomas or provide second opinions.
Treatment of Melanoma on the Skin
Surgeons biopsy or remove moles or melanomas, or re-excise biopsied melanomas. If necessary, plastic surgeons will be consulted.
Plastic surgery for skin cancer
Treatment of Merkel Cell Carcinoma
We have a very active multidisciplinary clinic involving dermatology, surgery, radiation oncology and medical oncology focusing on Merkel cell carcinoma. The Merkel cell carcinoma study team maintains a large database to follow the progress of patients across all Harvard-affiliated hospitals.
Learn more about Merkel Cell Carcinoma
Early Detection of Regional Disease
Oncology surgeons who take part in this program perform sentinel lymph node mapping to detect microscopic amounts of tumor that may have spread to lymph nodes. The sentinel lymph node mapping and biopsy technique is a new procedure that is rapidly becoming an integral part of treating cutaneous cancers.
Multinodality and Adjuvant Treatment of Regional Disease
Surgeons and oncologists treat patients who have melanoma already in the lymph nodes.
Treatment of Recurrent and Metastatic Disease
Medical and radiation oncologists treat disease with conventional and experimental regimens of chemotherapy, radiation, or immunotherapy for widespread disease.
Investigational Diagnostic and Treatment Methods
The Cutaneous Oncology Program participates in various experimental clinical trials, investigating new treatments for cutaneous cancers.
